메뉴 건너뛰기




Volumn 196, Issue 2, 2008, Pages 155-159

Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy

Author keywords

Parathyroidectomy; Percutaneous ethanol injection therapy; Secondary hyperparathyroidism; Tertiary hyperparathyroidism

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCITRIOL; CALCIUM; HEMOGLOBIN; LIDOCAINE; PARATHYROID HORMONE; PHOSPHORUS;

EID: 47049120677     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.037     Document Type: Article
Times cited : (7)

References (20)
  • 1
    • 0028942727 scopus 로고
    • Resistance to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure
    • Fukagawa M., Fukuda N., Yi H., et al. Resistance to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 10 (1995) 316-319
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 316-319
    • Fukagawa, M.1    Fukuda, N.2    Yi, H.3
  • 2
    • 0027217909 scopus 로고
    • Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients
    • 1436-3
    • Fukuda N., Tanaka H., Tominaga Y., et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92 (1993) 1436-3
    • (1993) J Clin Invest , vol.92
    • Fukuda, N.1    Tanaka, H.2    Tominaga, Y.3
  • 3
    • 0031764391 scopus 로고    scopus 로고
    • Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure
    • Llach F., and Yudd M. Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure. Am J Kidney Dis 32 suppl (1998) S3-S12
    • (1998) Am J Kidney Dis , vol.32 , Issue.SUPPL
    • Llach, F.1    Yudd, M.2
  • 4
    • 0021809284 scopus 로고
    • Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism
    • Solbiati L., Giangrande A., De Pra L., et al. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 155 (1985) 607-610
    • (1985) Radiology , vol.155 , pp. 607-610
    • Solbiati, L.1    Giangrande, A.2    De Pra, L.3
  • 5
    • 0031757894 scopus 로고    scopus 로고
    • Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism
    • Fletcher S., Kanagasundaram N.S., Rayner H.C., et al. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 13 (1998) 1311-1317
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 1311-1317
    • Fletcher, S.1    Kanagasundaram, N.S.2    Rayner, H.C.3
  • 6
    • 0026521310 scopus 로고
    • Ultrasound guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism
    • Giangrande A., Catiglioni A., Solbiati L., et al. Ultrasound guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 7 (1992) 412-421
    • (1992) Nephrol Dial Transplant , vol.7 , pp. 412-421
    • Giangrande, A.1    Catiglioni, A.2    Solbiati, L.3
  • 7
    • 0032976835 scopus 로고    scopus 로고
    • Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients
    • Kakuta T., Fukagawa M., Fujisaki T., et al. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 33 (1999) 109-119
    • (1999) Am J Kidney Dis , vol.33 , pp. 109-119
    • Kakuta, T.1    Fukagawa, M.2    Fujisaki, T.3
  • 8
    • 1342263701 scopus 로고    scopus 로고
    • Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism
    • De Barros Gueiros J.E., Chammas M.C., Gerhard R., et al. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism. Nephrol Dial Transplant 19 (2004) 657-663
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 657-663
    • De Barros Gueiros, J.E.1    Chammas, M.C.2    Gerhard, R.3
  • 9
    • 0038353294 scopus 로고    scopus 로고
    • Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by color Doppler ultrasonography
    • Tanaka R., Kakuta T., Fujisaki T., et al. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by color Doppler ultrasonography. Nephrol Dial Transplant 18 suppl 3 (2003) iii58-iii61
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.SUPPL. 3
    • Tanaka, R.1    Kakuta, T.2    Fujisaki, T.3
  • 10
    • 0037677258 scopus 로고    scopus 로고
    • Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients
    • iii50-iii2
    • Yamamoto H., Katoh N., Takeyama H., et al. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 18 suppl 3 (2003) iii50-iii2
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.SUPPL. 3
    • Yamamoto, H.1    Katoh, N.2    Takeyama, H.3
  • 11
    • 83055172414 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 suppl (2003) S1-S201
    • (2003) Am J Kidney Dis , vol.42 , Issue.SUPPL
  • 12
    • 0033995592 scopus 로고    scopus 로고
    • Presence of sonographically detectable parathyroid glands can predict resistance to oral pulse-dose calcitriol treatment of secondary hyperparathyroidism
    • Katoh N., Nakayama M., Shigematsu T., et al. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulse-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 35 (2000) 465-468
    • (2000) Am J Kidney Dis , vol.35 , pp. 465-468
    • Katoh, N.1    Nakayama, M.2    Shigematsu, T.3
  • 13
    • 0021361469 scopus 로고
    • Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation
    • Akerstrom G., Malmaeus J., Grimelius L., et al. Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation. Scand J Urol Nephrol 18 (1984) 75-84
    • (1984) Scand J Urol Nephrol , vol.18 , pp. 75-84
    • Akerstrom, G.1    Malmaeus, J.2    Grimelius, L.3
  • 14
    • 0030992925 scopus 로고    scopus 로고
    • Histology: pathophysiology and indications for surgical treatment of renal hyperparathyroidism
    • Tominaga Y., Tanaka Y., Sato K., et al. Histology: pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13 (1997) 78-86
    • (1997) Semin Surg Oncol , vol.13 , pp. 78-86
    • Tominaga, Y.1    Tanaka, Y.2    Sato, K.3
  • 15
    • 0033400142 scopus 로고    scopus 로고
    • Medical and surgical aspects of parathyroidectomy
    • Fukagawa M., Tominaga Y., Kitaoka M., et al. Medical and surgical aspects of parathyroidectomy. Kidney Int 73 suppl (1999) S65-S69
    • (1999) Kidney Int , vol.73 , Issue.SUPPL
    • Fukagawa, M.1    Tominaga, Y.2    Kitaoka, M.3
  • 16
    • 33646493386 scopus 로고    scopus 로고
    • Meta-analysis of biochemical and patient-level effects of calcimimetic therapy
    • Strippoli G.F., Palmer S., Tong A., et al. Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 47 (2006) 715-726
    • (2006) Am J Kidney Dis , vol.47 , pp. 715-726
    • Strippoli, G.F.1    Palmer, S.2    Tong, A.3
  • 17
    • 0027983607 scopus 로고
    • Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients
    • Fukagawa M., Kitaoka M., Yi H., et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68 (1994) 221-228
    • (1994) Nephron , vol.68 , pp. 221-228
    • Fukagawa, M.1    Kitaoka, M.2    Yi, H.3
  • 18
    • 31644434557 scopus 로고    scopus 로고
    • Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?
    • Richards M.L., Wormuth J., Bingener J., et al. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?. Surgery 139 (2006) 174-180
    • (2006) Surgery , vol.139 , pp. 174-180
    • Richards, M.L.1    Wormuth, J.2    Bingener, J.3
  • 19
    • 0038015184 scopus 로고    scopus 로고
    • Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients
    • Fukagawa M., Kitaoka M., Tominaga Y., et al. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 18 suppl 3 (2003) iii31-iii33
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.SUPPL. 3
    • Fukagawa, M.1    Kitaoka, M.2    Tominaga, Y.3
  • 20
    • 0031722768 scopus 로고    scopus 로고
    • Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism
    • Numano M., Tominaga Y., Uchida K., et al. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 22 (1998) 1098-1102
    • (1998) World J Surg , vol.22 , pp. 1098-1102
    • Numano, M.1    Tominaga, Y.2    Uchida, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.